Stem Cell Assurance Outlines Primary Business Initiatives

BOCA RATON, Fla., Nov. 22, 2010 /PRNewswire/ -- Stem Cell Assurance, Inc. (Pink Sheets: SCLZ) announced today that the Company will be focusing on four business development initiatives – Lipo Rejuvenation Centers, Cellular Treatment Programs, Laboratory Science Investigations, and its Skincare Brand, Stem Cellutrition™.  

The Company intends to open its first Lipo Rejuvenation Center – a pilot program -- where patients can undergo liposuction procedures and elect to have cosmetic fat transfer in a safe, friendly facility. In addition, the Company is exploring ways to become more active in providing Cellular Therapies (primarily using adult stem cells). The Company expects to identify certain Cosmetic/Aesthetic procedures where adipose (fat) derived stem cells would play a role in these treatments.

Stem Cell Assurance is actively seeking a location for a laboratory and additional office space which will enable the laboratory, once operational, to commence its adipose derived stem cell storage program.  The Company intends to eventually expand the laboratory capabilities so that it may become more involved in the science and medical work needed to provide the Company with data, information, and possible Intellectual Property needed to differentiate Stem Cell Assurance from other companies in the stem cell sector.  

Stem Cellutrition™, a wholly – owned subsidiary of the Company, has been slowly introducing its cosmetic skincare products.  These plant stem cell-based facial creams and products are currently being sold online, as well as at industry conferences and tradeshows.  Further sales strategies include a potential infomercial and the appointment of a brand director to oversee and implement an ambitious domestic and international marketing plan.    

Mark Weinreb, CEO, stated, "It is important to identify our business and maintain a focused approach to our initiatives with respect to the planning and implementation of our programs.  As our strategies evolve, we believe we will present a company that has novel and exciting programs that will help influence the adult stem cell field."

About Stem Cell Assurance

Stem Cell Assurance, Inc.'s goal is to become a medical center of excellence using cell and tissue regenerative therapy protocols, primarily involving a patient's own (autologous) adult stem cells (non-embryonic), allowing patients to undergo cellular-based treatments. As more and more cellular therapies become standard of care, the Company believes its strength will be its focus on the unity of medical and scientific explanations for its future clinical procedures and outcomes and its incorporation of adult stem cell collection and storage services for future personal medical applications. The Company intends to offer, through its "Lipo Rejuvenation Centers," the collection of adipose tissue for use in cosmetic treatments and for the separation and storage of adult stem cells. The Company also operates a division, Stem Cellutrition™, which offers and sells facial creams and products.

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  For this purpose, any statements contained in this release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "may", "will", "expect", "believe", "explore", "consider", "anticipate", "intend", "could", "estimate", "plan", "hope" or "continue" or the negative variations of those words or comparable terminology are intended to identify forward-looking statements. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events or results to differ materially from those projected in the forward-looking statements as a result of various factors and other risks. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and the Company undertakes no obligation to update such statements.

SOURCE Stem Cell Assurance, Inc.